Study of the effect of formulation parameters/variables to control the nanoencapsulation of hydrophilic drug via double emulsion technique

Journal of Biomedical Nanotechnology

Volumn 7, Issue 2, 2011, Pages 255-262

  Ayoub, Mohamed ^a,b,c   Ahmed, Naveed ^a,b   Kalaji, Nader ^a,b   Charcosset, Catherine ^a,b   Magdy, Ayoub ^c   Fessi, Hatem ^a,b   Elaissari, Abdelhamid ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Biodegradable polymer; Double emulsion; Encapsulation; Hydrophilic drug; Nanoparticles

Indexed keywords

ACTIVE MOLECULES; BIODEGRADABLE NANOPARTICLE; DOUBLE EMULSIONS; ENCAPSULATION EFFICIENCY; EVAPORATION METHOD; HYDROPHILIC AGENTS; HYDROPHILIC DRUGS; MODEL DRUGS; NANO-ENCAPSULATION; NANO-SIZE PARTICLES; POLOXAMER; POLY VINYL PYRROLIDONE; SIZE AND SIZE DISTRIBUTIONS; STABILIZER CONCENTRATION; STIRRING SPEED; SUBMICRON; TWEEN 80;

BIODEGRADABLE POLYMERS; ENCAPSULATION; ETHYLENE GLYCOL; HYDROPHILICITY; NANOPARTICLES; PARTICLE SIZE ANALYSIS; POLYCAPROLACTONE; TRANSMISSION ELECTRON MICROSCOPY;

EMULSIFICATION;

DICHLOROMETHANE; MACROGOL; NANOCAPSULE; POLOXAMER; POLYCAPROLACTONE; POLYSORBATE 80; POLYVINYL ALCOHOL; POVIDONE; STILBENE DERIVATIVE; TYLOXAPOL; FLUORESCENT DYE; NANOPARTICLE; POLYESTER;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOUBLE EMULSION EVAPORATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; EMULSION; EVAPORATION; MEMBRANE STABILIZATION; NANOENCAPSULATION; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; CHEMICAL PHENOMENA; CHEMISTRY; DRUG STABILITY; METHODOLOGY; ULTRASTRUCTURE;

CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; EMULSIONS; FLUORESCENT DYES; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PARTICLE SIZE; POLYESTERS; POLYVINYL ALCOHOL;

EID: 79960994844     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2011.1279     Document Type: Article

References (42)

1. S. Khoee and M. Yaghoobian, An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing Penicillin G in double emulsion. Eur. J. Med. Chem. 44, 2392 (2009).
2. M. N. V. R. Kumar and R. J. Mumper, A special issue on nanotechnology in advanced drug delivery. J. Biomed. Nanotechnol. 3, 1 (2007).
3. S. Gill, R. Löbenberg, T. Ku, S. Azarmi, W. Roa, and E. J. Prenner, Nanoparticles: Characteristics, mechanisms of action, and toxicity in pulmonary drug delivery-A review. J. Biomed. Nanotechnol. 3, 107 (2007).
4. S. M. Moghimi, G. Chirico, and A. Zaichenko, A special issue on nano- and micro-technologies for biological targeting, tracking, imaging and sensing. J. Biomed. Nanotechnol. 5, 611 (2009).
5. A. T. Florence, The oral absorption of micro- and nanoparticulate: Neither exceptional nor unusual. Pharm. Res. 14, 259 (1997).
6. S. A. Kumar and M. I. Khan, Heterofunctional nanomaterials: Fabrication, properties and applications in nanobiotechnology. J. Nanosci. Nanotechnol. 10, 4124 (2010).
7. J. Kreuter and M. Dekker, Nanoparticles in colloidal drug delivery systems, edited by New York (1994), p. 219.
8. R. Diab, M. Hamoudeh, O. Boyron, A. Elaissari, and H. Fessi, Microencapsulation of cytarabine using poly (ethylene glycol)- poly (epsilon-caprolactone) diblock copolymers as surfactant agents. Drug Dev. Ind. Pharm. 36, 456 (2010).
9. R. A. Jain, The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide) (PLGA) devices. Biomaterials 21, 2475 (2000).
10. M. Stevanovic, A. Radulovic, B. Jordovic, and D. Uskokovic, Poly (DL-lactide-co-glycolide) nanospheres for the sustained release of folic acid. J. Biomed. Nanotechnol. 4, 349 (2008).
11. A. Mukerjee and V. Pruthi, Oral insulin delivery by polymeric nanospheres. J. Biomed. Nanotechnol. 3, 68 (2007).
12. A. Deloge, N. Kalaji, N. S. Othman, V. S. Lin, P. Farge, and H. Fessi, Preparation conditions effect on the morphology and release kinetics of biodegradable particles: A mathematical approach. J. Nanosci. Nanotechnol. 8, 1 (2008).
13. S. Murugesan, S. Ganesan, R. K. Averineni, M. Nahar, P. Mishra, and N. Kumar, PEGylated Poly (Lactide-co-Glycolide) (PLGA) nanoparticulate delivery of docetaxel: Synthesis of diblock copolymers, optimization of preparation variables on formulation characteristics and in vitro release studies. J. Biomed. Nanotechnol. 3, 52 (2007).
14. Y. Yeo, N. Back, and K. Park, Microencapsulation methods for delivery of protein drugs. Biotechnol. Bioprocess. Eng. 6, 213 (2001).
15. B. Erdem, E. D. Sudol, V. L. Dimoine, and M. S. El-Aasser, Encapsulation of inorganic particles via miniemulsion polymerization. III. Characterization of encapsulation. J. polymer science: Part A: Polymer chemistry 3, 4441 (2000).
16. P. Legrand, S. Lesieur, A. Bochot, R. Gref, W. Raatjes, G. Barratt, and C. Vauthier, Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation. Int. J. Pharm. 344, 33 (2007).
17. M. Chorny, I. Fishbein, H. D. Danenberg, and G. Golomb, Lipophilic drug loaded nanospheres prepared by nanoprecipitation: Effect of formulation variables on size, drug recovery and release kinetics. J. Controlled Release 83, 389 (2002).
18. F. Lince, D. L. Marchisio, and A. A. Barresi, Strategies to control the particle size distribution of poly-e-caprolactone nanoparticles for pharmaceutical applications. J. Colloid Interface. Sci. 322, 505 (2008).
19. D. Quintanar, E. Allémann, H. Fessi, and E. Doelker, Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers. Drug Dev. Ind. Pharm. 24, 1113 (1998).
20. S. Shafiq, F. Shakeel, S. Talegaonkar, F. J. Ahmad, R. K. Khar, and M. Ali, Design and development of oral oil in water ramipril nanoemulsion formulation: In vitro and in vivo assessment. J. Biomed. Nanotechnol. 3, 28 (2007).
21. Y. Nakada, E. Fattal, M. Foulquier, and P. Couvreur, Pharmacokinetics and biodistribution of oligonucleotide adsorbed onto poly (isobutylcyanoacrylate) nanoparticles after intravenous administration in mice. Pharm. Res. 13, 38 (1996).
22. A. Lamprecht, N. Ubriche, M. H. Perez, and C.-M. Lehr, Influence of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int. J. Pharm. 196, 177 (2000).
23. R. Alex and R. Bodmeier, Encapsulation of water-soluble drugs by a modified solvent evaporation method, I. Effect of process and formulation variables on drug entrapment. J. Microencapsul. 7, 347 (1989).
24. S. Cohen, T. Yoshioka, M. Lucarelli, L. H. Hwang, and R. Langer, Controlled delivery systems for proteins based on poly (lactic: glycolic acid) microspheres. Pharm. Res. 8, 713 (1991).
25. M. D. Blanco and M. J. Alonso, Development and characterization of protein-loaded poly (lactide-co-glycolide) nanospheres. Eur. J. Pharm. Biopharm. 43, 287 (1997).
26. D. Lemoine and V. Préat, Polymeric nanoparticles as delivery system for influenza virus glycoproteins. J. Controlled Release. 54, 15 (1998).
27. M. Tobío, R. Gref, A. Sánchez, R. Langer, and M. J. Alonso, Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm. Res. 15, 270 (1998).
28. N. Garti, Double emulsion-scope, limitations and new achievements. Colloid surf. A 233, 123 (1997).
29. C. E. Mora-Heuretas, H. Fessi, and A. Elaissari, Polymer based nanocapsules for drug delivery. Int. J. Pharm. 385, 113 (2010).
30. A. Lamprecht, N. Ubrich, M. H. Perez, C.-M. Lehr, M. Hoffman, and P. Maincent, Biodegradable monodispersed nanoparticles prepared by homogenization-emulsification. Int. J. Pharm. 184, 97 (1999).
31. C. Perez, A. Sanchez, D. Putnam, D. Ting, R. Langer, and M. J. Alonso, Poly (lactic acid)-poly (ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA. J. Controlled Release 752, 224 (2001).
32. Y. Jeong, N. Hee-Sam, S. Dong-Hyuk, K. Dong-Gon, L. Hyun- Chul, J. Mi-Kyeong, N. Sang-Kwon, R. Sung-Hee, K. Sun-Il, and N. Jae-Woon, Ciprofloxacin-encapsulated poly (DL-lactide-coglycolide) nanoparticles and its antibacterial activity. Int. J. Pharm. 352, 317 (2008).
33. L. Baudonnet, J.-L. Grossiord, and F. Rodriguez, Effect of dispersion stirring speed on the particle size distribution and rheological properties of three carbomers. J. dispersion sci. Tech. 25, 83 (2004).
34. M. A. Aravand and M. A. Semsarzadeh, Particle formation by emulsion inversion method: Effect of the stirring speed on inversion and formation of spherical Particles. Macromol. Symp. 274, 141 (2008).
35. H. Jeffery, S. S. Davis, and D. T. O'Hagan, The preparation and characterization of poly (lactide-co-glycolide) microparticles. Int. J. Pharm. 77, 169 (1991).
36. Y. Yang, T. S. Chung, and N. Ping Ng, Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 22, 231 (2001).
37. R. Jalil and J. R. Nixon, Biodegradable poly (lactic acid) and poly (lactide-co-glycolide) microcapsules: Problems associated with preparative techniques and release properties. J. Microencapsul. 7, 297 (1990).
38. M. Singh and D. O'Hagan, The preparation and characterization of polymeric antigen delivery systems for oral administration. Adv. Drug Del. Rev. 34, 285 (1998).
39. D. Quintanar-Guerrero, H. Fessi, E. Allémann, and E. Doelker, Influence of stabilizing agents and preparatives variables on the formation of poly (D, L-lactic acid) nanoparticles by an emulsificationdiffusion technique. Int. J. Pharm. 143, 133 (1996).
40. M. Hamoudeh and H. Fessi, Preparation, characterization and surface study of poly-epsilon caprolactone magnetic microparticles. J. Colloid Interface. Sci. 300, 584 (2006).
41. S. Feng and G. Huang, Effects of emulsifiers release of paclitaxel (Taxol®) from nanospheres polymers. J. Controlled Release 71, 53 (2001).
42. S. S. Guterres, H. Fessi, G. Barratt, G. J. P. Devissaguet, and F. Puisieux, Poly (D, L-lactide) nanocapsules containing diclofenac, I. Formulation and stability study. Int. J. Pharm. 113, 57 (1995).